Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

被引：0
|
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2010年 / 26卷 / 11期
关键词：
D O I：
10.2165/11206250-000000000-00000
中图分类号：
学科分类号：
摘要：
Low-dose aspirin is a highly effective therapy for the prevention of cardiovascular (CV) events in high-risk patients. However, poor compliance and discontinuation are common among patients receiving such therapy, which increases their risk of CV events. © 2010 Adis Data Information BV. All rights reserved.
引用
收藏
页码：24 / 26
页数：2
相关论文
共 50 条
  • [1] Cardiovascular events after discontinuation of low-dose aspirin
    Pareek, Manan
    Kristensen, Steen D.
    Grove, Erik L.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 75 - 78
  • [2] Aspirin discontinuation increases risk of cardiovascular events
    Huynh, Karina
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (12) : 696 - 696
  • [3] Aspirin discontinuation increases risk of cardiovascular events
    Karina Huynh
    [J]. Nature Reviews Cardiology, 2017, 14 : 696 - 696
  • [4] Discontinuation of Low-Dose Aspirin Therapy After Peptic Ulcer Bleeding Increases Risk of Death and Acute Cardiovascular Events
    Derogar, Maryam
    Sandblom, Gabriel
    Lundell, Lars
    Orsini, Nicola
    Bottai, Matteo
    Lu, Yunxia
    Sadr-Azodi, Omid
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (01) : 38 - 42
  • [5] Low-Dose Aspirin Therapy for Cardiovascular PreventionQuantification and Consequences of Poor Compliance or Discontinuation
    Johan Herlitz
    Peter P. Tóth
    Jørgen Næsdal
    [J]. American Journal of Cardiovascular Drugs, 2010, 10 : 125 - 141
  • [6] Low-Dose Aspirin Therapy for Cardiovascular Prevention Quantification and Consequences of Poor Compliance or Discontinuation
    Herlitz, Johan
    Toth, Peter P.
    Naesdal, Jorgen
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (02) : 125 - 141
  • [7] Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events A Swedish Nationwide, Population-Based Cohort Study
    Sundstroem, Johan
    Hedberg, Jakob
    Thuresson, Marcus
    Aarskog, Pernilla
    Johannesen, Kasper Munk
    Oldgren, Jonas
    [J]. CIRCULATION, 2017, 136 (13) : 1183 - +
  • [8] Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
    Leggio, M.
    Bendini, M. G.
    Caldarone, E.
    Lombardi, M.
    Severi, P.
    D'Emidio, S.
    Stavri, D. C.
    Armeni, M.
    Bravi, V.
    Mazza, A.
    [J]. DIABETES & METABOLISM, 2018, 44 (03) : 217 - 225
  • [9] Effect of Low-Dose Aspirin on Primary Prevention of Cardiovascular Events in Japanese Diabetic Patients at High Risk
    Okada, Sadanori
    Morimoto, Takeshi
    Ogawa, Hisao
    Sakuma, Mio
    Soejima, Hirofumi
    Nakayama, Masafumi
    Sugiyama, Seigo
    Jinnouchi, Hideaki
    Waki, Masako
    Doi, Naofumi
    Horii, Manabu
    Kawata, Hiroyuki
    Somekawa, Satoshi
    Soeda, Tsunenari
    Uemura, Shiro
    Saito, Yoshihiko
    [J]. CIRCULATION JOURNAL, 2013, 77 (12) : 3023 - 3028
  • [10] Low-dose aspirin increases risk of major haemorrhages
    [J]. Reactions Weekly, 2006, 1123 (1) : 1 - 1
12345